Scan to Download
One power score. Smarter investment decisions
Aeon Biopharma Inc
AEON0.763USD
+0.003+0.38%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
8.80MMarket Cap
LossP/E TTM
Aeon Biopharma Inc
0.763
+0.003+0.38%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2022Q4
FY2022Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
74.24%-2.09M
8.03%-7.91M
94.36%-621.00K
81.13%-2.96M
---8.12M
---8.60M
-30.34%-11.02M
-35.85%-15.66M
---8.45M
---11.53M
Net income from continuing operations
-104.05%-6.64M
107.71%9.10M
100.53%2.08M
-115.87%-6.17M
--164.11M
---118.02M
-1029.79%-390.49M
472.38%38.88M
---34.56M
---10.44M
Operating gains losses
-16.67%20.00K
-24.00%19.00K
-4.17%23.00K
-7.41%25.00K
--24.00K
--25.00K
-25.00%24.00K
107.69%27.00K
--32.00K
--13.00K
Other non-cash items
100.01%16.00K
13.15%72.16M
-100.78%-2.96M
100.00%0.00
---161.23M
--63.77M
1835.53%380.80M
-7329.70%-72.30M
--19.67M
--1.00M
Change in working capital
125.47%537.00K
-6152.08%-5.81M
327.24%3.29M
87.18%-577.00K
---2.11M
--96.00K
-130.62%-1.45M
-41.72%-4.50M
--4.74M
---3.18M
-Change in prepaid expenses
-85.40%53.00K
-340.32%-298.00K
177.88%257.00K
-249.17%-1.26M
--363.00K
--124.00K
-547.06%-330.00K
-11900.00%-360.00K
---51.00K
---3.00K
Cash from non-recurring investing activities
Cash from operating activities
74.24%-2.09M
8.03%-7.91M
94.36%-621.00K
81.13%-2.96M
---8.12M
---8.60M
-30.34%-11.02M
-35.85%-15.66M
---8.45M
---11.53M
Investing cash flow
Net cash from continuing investing activities
--0.00
--4.00K
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
--9.00K
--228.00K
Capital expenditures
--0.00
--4.00K
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
--9.00K
--228.00K
Net cash flow from disposal of fixed assets
--0.00
--4.00K
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
--9.00K
--228.00K
Cash from non-current investing activities
Net cash flow from investing activities
--0.00
---4.00K
----
----
----
--0.00
100.00%0.00
100.00%0.00
---9.00K
---228.00K
Financing cash flow
Cash flow from continuous financing activities
-99.16%84.00K
266.92%18.35M
--97.00K
--50.00K
--10.00M
--5.00M
100.00%0.00
-100.00%0.00
---3.99M
--32.50M
Net cash flow from debt Issuance/repayment
----
----
--0.00
--0.00
--10.00M
--5.00M
100.00%0.00
-100.00%0.00
---3.99M
--32.50M
Net cash flow from common stock issuance/repurchase
--84.00K
--18.35M
--97.00K
--50.00K
----
----
----
----
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-99.16%84.00K
266.92%18.35M
--97.00K
--50.00K
--10.00M
--5.00M
100.00%0.00
-100.00%0.00
---3.99M
--32.50M
Net cash flow
Beginning cash balance
570.47%10.45M
-99.75%13.00K
-97.05%537.00K
-89.83%3.44M
--1.56M
--5.16M
-18.12%18.18M
2219.47%33.84M
--22.20M
--1.46M
Current period cash flow changes
-206.53%-2.01M
389.81%10.43M
95.24%-524.00K
81.45%-2.91M
--1.88M
---3.60M
11.53%-11.02M
-175.51%-15.66M
---12.46M
--20.74M
Ending cash balance
145.18%8.44M
570.47%10.45M
-99.82%13.00K
-97.05%537.00K
--3.44M
--1.56M
-26.54%7.16M
-18.12%18.18M
--9.75M
--22.20M
Free cash flow
---2.09M
7.99%-7.91M
----
----
----
---8.60M
-30.20%-11.02M
-33.21%-15.66M
---8.46M
---11.76M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
